For Immediate Release
Company name: DAIICHI SANKYO COMPANY, LIMITED
Representative: George Nakayama, Representative Director, President and CEO
(Code no.: 4568, First Section, Tokyo Stock Exchange)
Please address inquiries to Noriaki Ishida, Executive Officer,
Vice President, Corporate Communications Department
Telephone: +81-3-6225-1126
http://www.daiichisankyo.com
Daiichi Sankyo Appoints New Group Corporate Officers
TOKYO, Japan (February 24, 2017) – Daiichi Sankyo Company, Limited today announced the appointment of new Group corporate officers effective from April 1, 2017.
1. DAIICHI SANKYO CO., LTD.
|
Name
|
Current Responsibilities
|
New Responsibilities
|
|
Toshiaki Sai
|
Member of the Board
Senior Executive Officer
Head of Corporate Strategy Div.
|
Member of the Board
Senior Executive Officer
Head of Global Brand Strategy Div.
|
|
Noriaki Ishida
|
Executive Officer
Vice President of Corporate Communications Dept., Corporate Management Div.
|
Executive Officer
Vice President of Corporate Communications Dept., Corporate Strategy & Management Div.
|
|
Junichi Koga
|
Executive Officer
Head of R&D Div. and Vice President of Research Technology Function, and in charge of Biologics
|
Executive Officer
Head of R&D Div.
|
|
Yoshihiro Aoyagi
|
Corporate Officer
Vice President of Legal Affairs Dept., General Affairs & Human Resources Div.
|
Executive Officer
Head of Corporate Affairs Div.
|
|
Yuichi Kubo
|
Corporate Officer
Vice President of Business Development & Licensing Dept., Corporate Strategy Div.
|
Executive Officer
Vice President of Business Development & Licensing Dept.
|
|
Kentaro Takamura
|
Corporate Officer
Vice President of Finance & Accounting Dept., Corporate Management Div.
|
Corporate Officer
Vice President of Finance & Accounting Dept., Corporate Strategy & Management Div.
|
|
Kenji Katsumi
|
Corporate Officer
Vice President of Corporate Business Management Dept., Corporate Management Div.
|
Corporate Officer
Vice President of Corporate Affairs & Procurement Dept., Corporate Affairs Div.
|
|
Shinichi Tobita
|
Vice President of Marketing Dept., Sales & Marketing Div.
|
Corporate Officer
Vice President of Marketing Dept., Sales & Marketing Div.
|
|
Hironobu Furuta
|
Vice President of General Affairs & Procurement Dept., General Affairs & Human Resources Div.
|
Corporate Officer
Vice President of Human Resources Dept., Corporate Affairs Div.
|
|
Takeshi Hamaura
|
Vice President of CMC Planning Dept., Pharmaceutical Technology Div.
|
Corporate Officer
Head of Pharmaceutical Technology Div. and Vice President of CMC Planning Dept.
|
|
Hideyuki Hirano
|
Vice President of Sales Planning Dept., Sales & Marketing Div.
|
Corporate Officer
Vice President of Sales Planning Dept., Sales & Marketing Div.
|
|
Shoji Hirashima
|
Vice President of Corporate Strategy Dept. and Senior Director of Oncology Business Group, Corporate Strategy Div.
|
Corporate Officer
Vice President of Corporate Business Management Dept., Corporate Strategy & Management Div.
|
|
Koji Ogawa
|
Vice President of Business Planning Dept., ASCA Company
|
Corporate Officer
President of ASCA Company
|
◇Shuji Handa (current Executive Officer) will become Corporate Advisor as of April 1st, 2017.
◇Norimasa Kamura (current Executive Officer) will become Corporate Advisor as of April 1st, 2017.
◇Kazuo Sato (current Corporate Officer) will become Corporate Advisor as of April 1st, 2017.
◇Naoyuki Kishi (current Corporate Officer) will be appointed the Member of the Board, DAIICHI SANKYO CHEMICAL PHARMA CO. LTD. as of April 1st, 2017.
【Management structure as of April 1st, 2017】
|
Position
|
Name
|
Responsibilities
|
|
Representative Director,
Chairman and CEO
|
George Nakayama
|
|
|
Representative Director,
Member of the Board,
President and COO
|
Sunao Manabe
|
|
|
Representative Director,
Member of the Board,
Executive Vice President and CFO
|
Kazunori Hirokawa
|
Head of Corporate Strategy & Management Div.
|
|
Member of the Board,
Senior Executive Officer
|
Toshiaki Sai
|
Head of Global Brand Strategy Div.
|
|
|
Katsumi Fujimoto
|
Head of Supply Chain Div.
|
|
|
Toshiaki Tojo
|
In charge of Vaccine Business
|
|
Member of the Board (Outside)
|
Noritaka Uji
|
|
|
|
Hiroshi Toda
|
|
|
|
Naoki Adachi
|
|
|
|
Tsuguya Fukui
|
|
|
Member of the Audit and Supervisory Board
|
Hideyuki Haruyama
|
|
|
|
Kazuyuki Watanabe
|
|
|
Member of the Audit and Supervisory Board (Outside)
|
Akiko Kimura
|
|
|
|
Yutaka Katagiri
|
|
|
Senior Executive Officer
|
Glenn Gormley
|
In charge of R&D
|
|
|
Satoru Kimura
|
Head of Sales & Marketing Div.
|
|
Executive Officer
|
Noriaki Ishida
|
Vice President of Corporate Communications Dept., Corporate Strategy & Management Div.
|
|
|
Ryoji Nagasaka
|
Vice President of Secretariat Dept.
|
|
|
Junichi Koga
|
Head of R&D Div.
|
|
|
Koichi Akahane
|
Vice President of Oncology Function, R&D Div.
|
|
|
Yoshihiro Aoyagi
|
Head of Corporate Affairs Div.
|
|
|
Yuichi Kubo
|
Vice President of Business Development & Licensing Dept.
|
|
Corporate Officer
|
Kohei Wada
|
Vice President of Development Function, R&D Div.
|
|
|
Masahiko Ohtsuki
|
Vice President of Research Function, R&D Div.
|
|
|
Kentaro Takamura
|
Vice President of Finance & Accounting Dept., Corporate Strategy & Management Div.
|
|
|
Ryoichi Watanabe
|
Vice President of Internal Audit Dept.
|
|
|
Junichi Fukute
|
Vice President of Supply Chain Planning Dept., Supply Chain Div.
|
|
|
Kenji Katsumi
|
Vice President of Corporate Affairs & Procurement Dept., Corporate Affairs Div.
|
|
|
Kentaro Murakawa
|
Vice President of Tokyo Branch,
Sales & Marketing Div.
|
|
|
Hirosumi Izawa
|
Head of Quality & Safety Management Div.
|
|
|
Shinichi Tobita
|
Vice President of Marketing Dept.,
Sales & Marketing Div.
|
|
|
Hironobu Furuta
|
Vice President of Human Resources Dept., Corporate Affairs Div.
|
|
|
Takeshi Hamaura
|
Head of Pharmaceutical Technology Div. and Vice President of CMC Planning Dept.
|
|
|
Hideyuki Hirano
|
Vice President of Sales Planning Dept.
Sales & Marketing Div.
|
|
|
Shoji Hirashima
|
Vice President of Corporate Business Management Dept., Corporate Strategy & Management Div.
|
|
|
Koji Ogawa
|
President of ASCA Company
|
2. DAIICHI SANKYO ESPHA CO., LTD.
|
Name
|
Current Responsibilities
|
New Responsibilities
|
|
Shigeyoshi Obara
|
Vice President of Kyushu Branch, Sales & Marketing Div., DAIICHI SANKYO CO., LTD.
|
Member of the Board
Deputy head of Sales & Marketing Div.
|
3. KITASATO DAIICHI SANKYO VACCINE CO., LTD.
* Jun Hishida (current Executive Vice President) will retire on March 31st, 2017.